Skip to main content

Press Releases

August 30, 2017
Congresswoman Rosa DeLauro (CT-03) today released the following statement in response to the opioid epidemic in Connecticut and across the nation.
August 29, 2017
Congresswoman Rosa DeLauro (CT-03) today released the following statement denouncing the Trump Administration’s changes to the EEO-1 Form, which is used by the Equal Employment Opportunity Commission (EEOC) to collect equal pay data.
August 28, 2017
Congresswoman Rosa DeLauro (CT-03) today released the following statement marking the 21st anniversary of President Ronald Reagan signing into law gun safety legislation that banned armor-piercing ammunition.
August 26, 2017
Congresswoman Rosa DeLauro (CT-03) today released the following statement in response to President Trump’s directive to ban transgender individuals from joining the military.
August 26, 2017
Ninety-seven years ago today, women were granted the right to vote via the adoption of the 19th Amendment. As we recognize the enormous achievements women have made in all walks of life—from business to education to politics—we must also recommit to the work ahead.
August 21, 2017
Congresswoman Rosa DeLauro (CT-03) today released the following statement in response to President Trump’s speech regarding our nation’s military strategy in Afghanistan and South Asia.
August 21, 2017
Congresswoman Rosa DeLauro (CT-03) today released the following statement to mark the 53rd anniversary of President Lyndon B. Johnson signing the Economic Opportunity Act into law.
August 18, 2017
Congresswoman Rosa DeLauro (CT-03) today announced two Connecticut natives have joined her staff: Will Serio, from West Haven, is serving as Communications Director in the Washington, D.C. office, and Abdur Wali, from New Haven, has joined the New Haven office as a Congressional Aide Caseworker.
August 18, 2017
Congresswoman Rosa DeLauro (CT-03) today released the following statement celebrating National Health Center Week, which recognizes the importance of our nation’s Community Health Centers.
August 18, 2017
Congresswoman Rosa DeLauro (CT-03) today released the following statement in response to Mylan’s settlement agreement with the Department of Justice. Mylan, best known as the maker of the EpiPen, will pay federal authorities $465 million for overcharging the Medicaid program.